ID
37646
Descripción
Study ID: 104864/612 Clinical Study ID: 104864/612 Study Title: A Prospective, Open Label Phase II Study to Evaluate the Efficacy and Safety of Topotecan (HycamtinTM) in Combination with Carboplatin as First-line Chemotherapy in Patients with Ovarian Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: HycamtinTM Study Indication: Ovarian Cancer
Palabras clave
Versiones (1)
- 13/8/19 13/8/19 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
13 de agosto de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Topotecan (HycamtinTM) with Carboplatin as First-Line Chemotherapy in Patients with Ovarian Cancer; 104864/612
Prior to Second Cycle
- StudyEvent: ODM
Descripción
Computed tomography
Alias
- UMLS CUI-1
- C0040405
Descripción
X-Ray Computed Tomography, Performed
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0040405
- UMLS CUI [1,2]
- C0884358
Descripción
X-Ray Computed Tomography, Changed status
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0040405
- UMLS CUI [1,2]
- C0443172
Descripción
X-Ray Computed Tomography, Finding
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0040405
- UMLS CUI [1,2]
- C0243095
Descripción
X-Ray Computed Tomography, Date in time
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0040405
- UMLS CUI [1,2]
- C0011008
Descripción
Assessment of response
Alias
- UMLS CUI-1
- C0521982
- UMLS CUI-2
- C0220825
Descripción
Response to treatment, Evaluation, Performed
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0521982
- UMLS CUI [1,2]
- C0220825
- UMLS CUI [1,3]
- C0884358
Descripción
Response to treatment, Evaluation
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0521982
- UMLS CUI [1,2]
- C0220825
- UMLS CUI [1,3]
- C0884358
Descripción
Response to treatment, Evaluation Method
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0521982
- UMLS CUI [1,2]
- C2911685
Descripción
Response to treatment, Evaluation, Date in time
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0521982
- UMLS CUI [1,2]
- C0220825
- UMLS CUI [1,3]
- C0011008
Descripción
Response to treatment, Evaluation, Malignant Neoplasms
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0521982
- UMLS CUI [1,2]
- C0220825
- UMLS CUI [1,3]
- C0006826
Descripción
Serious adverse events
Alias
- UMLS CUI-1
- C1519255
Descripción
Status of the study
Alias
- UMLS CUI-1
- C0008976
- UMLS CUI-2
- C0449438
Similar models
Prior to Second Cycle
- StudyEvent: ODM
C0884358 (UMLS CUI [1,2])
C0443172 (UMLS CUI [1,2])
C0243095 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0220825 (UMLS CUI-2)
C0220825 (UMLS CUI [1,2])
C0884358 (UMLS CUI [1,3])
C0220825 (UMLS CUI [1,2])
C0884358 (UMLS CUI [1,3])
C2911685 (UMLS CUI [1,2])
C0220825 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0220825 (UMLS CUI [1,2])
C0006826 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,2])